In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 4, 1997, Pages 833-841

  Rotmensch, J ^a   Whitlock, J L ^a   Schwartz, J L ^a   Hines, J J ^a   Reba, R C ^a   Harper, P V ^a   Hoskins, W J ^a   Montz, F J ^a   Sherman, A I ^a   Anderson, B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

bismuth 212; ovarian carcinoma; Emmiting isotopes

Indexed keywords

BISMUTH; RADIOISOTOPE;

ALPHA RADIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RABBIT; RADIATION DOSE; RADIATION DOSE DISTRIBUTION;

EID: 0030971139     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70608-2     Document Type: Article

References (15)

1. JT Thigpen JA Blessing RB Vance Chemotherapy in ovarian cancer: present role and future prospects Semin Oncol 16 suppl 6 1989 58 61
2. RC Young LA Walton SS Ellenberg HD Homesley GD Wilbanks DG Decker Adjuvant therapy in stage I and stage II epithelial ovarian cancer N Engl J Med 322 1990 1021 1027
3. J Rotmensch RW Atcher J Hines M Toohill AL Herbst Comparison of short-lived high-LET α-emitting radionuclides lead-212 and bismuth-212 to low-LET x-rays on ovarian carcinoma Gynecol Oncol 35 1989 297 300
4. J Rotmensch RW Atcher J Hines D Grdina JS Schwartz M Toohill Development of α-emitting radionuclide lead-212 for the potential treatment of ovarian carcinoma Am J Obstet Gynecol 60 1989 789 797
5. VK Langmuir JK McGann F Buchegger RM Sutherland The effect of antigen concentration, antibody valence and size, and tumor architecture on antibody binding in multicell spheroids Nucl Med Biol 18 1991 753 764
6. PJ Early Radiation measurement and protection PJ Early DB Sodee Principles and practice of nuclear medicine 1995 Mosby–Year Book St. Louis 65 80
7. JL Schwartz CR Ashman RW Atcher BA Sedita JD Shadley J Tang Differential locus sensitivity to mutation induction by ionizing radiations of different LETs in Chinese hamster ovary K1 cells Carcinogenesis 12 1991 1721 1726
8. 4th ed EJ Hall Radiobiology for the radiologist 1994 Lippincott Philadelphia 29 73 Cell survival curves
9. Minitab data analysis software release 7 1989 Minitab State College (PA)
10. Autoradiography at the light microscrospic level 1988 Eastman Kodak Rochester (NY)
11. R Loevinger TF Budinger EE Watson MIRD primer for absorbed dose calculations 1988 Society of Nuclear Medicine New York
12. 212Bi Int J Nucl Med Biol 9 1982 83 84
13. DR Fisher The microdosimetry of monoclonal antibodies labeled with alpha-particles AJ Schlafke EE Watson Proceedings of the Fourth International Radiopharmaceutical Dosimetry Symposium; 1985 Nov 5-8 1986 Tennessee. Washington: U.S. Department of Energy Oak Ridge 26 36
14. WP McGuire WJ Hoskins MF Brady PR Kucera EE Partridge KY Look Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV epithelial ovarian cancer N Engl J Med 334 1996 1 6
15. SC Rubin WJ Hoskins TB Hakes M Markman JM Cain JL Lewis Jr Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk Am J Obstet Gynecol 159 1988 1094 1098